" /> " /> " />

Study to gauge cholesterol treatment in Jordan

13 June 2010

A nation-wide study will be conducted in Jordan by AstraZeneca and the Jordanian Endocrinology Society to gauge "under-treatment" of high blood cholesterol in the kingdom, Jordan Times has reported. The study is part of an international survey that is designed to determine levels of cholesterol control among patients currently undergoing treatment, according to Ayman Hammoudeh, a consultant interventional cardiologist. The latest studies conducted in the kingdom indicate that Jordan is among countries with a high incidence of high blood cholesterol.

A MEED Subscription...

Subscribe or upgrade your current MEED.com package to support your strategic planning with the MENA region’s best source of business information. Proceed to our online shop below to find out more about the features in each package.

Get Notifications